title: Screening for meticillin resistant Staphylococcus aureus (MRSA): who, when, and how?
authors.affiliation: Department of Clinical Microbiology, Glasgow Royal Infirmary, Glasgow G4 0SF, UK.
authors.forename: John E
authors.initials: JE
authors.lastname: Coia
authors.forename: Alistair T
authors.initials: AT
authors.lastname: Leanord
authors.forename: Jacqui
authors.initials: J
authors.lastname: Reilly
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D001365:Axilla / Q000382:microbiology; D002353:Carrier State / Q000175:diagnosis* / Q000382:microbiology / Q000517:prevention & control; D003428:Cross Infection / Q000175:diagnosis* / Q000382:microbiology / Q000517:prevention & control; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D009666:Nose / Q000382:microbiology; D010343:Patient Admission; D010356:Patient Isolation; D018579:Patient Selection; D010502:Perineum / Q000382:microbiology; D010614:Pharynx / Q000382:microbiology; D018570:Risk Assessment; D013203:Staphylococcal Infections / Q000175:diagnosis* / Q000382:microbiology / Q000517:prevention & control; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local